YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Investing.com -- Jefferies identified three biotechnology stocks that appear undervalued with strong commercial prospects despite a challenging macro environment. The firm noted that rising interest rates are pressuring small and mid-cap b…
Key Takeaways; Psychedelic Sector Optimi Health Plans to Initiate Phase 3 Clinical Trial Evaluating MDMA Therapy for Individuals with PTSD Eli Lilly Completed $2.8 Billion Acquisition of AtaiBeckley, Expanding its Mental Health Pipeline De…
Definium Therapeutics, Inc. (NASDAQ:DFTX) has now delivered a third consecutive positive Phase 3 readout for its LSD-based medication, the second in generalized anxiety disorder. The result puts the company on a viable route toward a poten…
Mid-cap U.S. healthcare stocks have exhibited strong momentum traits year to date, with several names earning A-range momentum grades that indicate stronger price performance trends relative to sector peers. Seeking Alpha's Quant Momentum…
The S&P 500 Index ($SPX) (SPY) closed down by -0.48% on Monday, the Dow Jones Industrial Average ($DOWI) (DIA) closed down by -0.29%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down by -0.82%. E-mini S&P futures (ESU26) fell -0.46%, and…
Healthcare stocks advanced Monday afternoon, with the NYSE Healthcare Index up 1.6% and the State St PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Definium Therapeutics' LSD eased the symptoms of anxiety, the company said Monday as shares took off again. Continue Reading
The S&P 500 Index ($SPX) (SPY) is down by -0.83% today, the Dow Jones Industrial Average ($DOWI) (DIA) is down by -0.53%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down by -1.39%. E-mini S&P futures (ESU26) are down -0.80%, and September E…
The S&P 500 Index ($SPX) (SPY) is down by -0.65% today, the Dow Jones Industrial Average ($DOWI) (DIA) is down by -0.20%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down by -1.48%. E-mini S&P futures (ESU26) are down -0.58%, and September E…
Company to host webcast tomorrow at 8:00 a.m. EDT NEW YORK, September 13, 2026--(BUSINESS WIRE)--Definium Therapeutics, Inc. ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of ther…
Stanley Druckenmiller's Duquesne Family Office recently filed its 13F for the second quarter. The firm opened new stakes in more than 40 stocks. Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) and Definium Therapeutics, Inc. (NASDAQ:DFTX) are t…
[FDA Headquarters] The Trump administration on Tuesday appointed the acting heads of the FDA units overseeing drugs, vaccines, and tobacco to permanent positions weeks after nominating White House advisor Heidi Overton as the agency's next…
Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.2% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for "Meridian Small Cap Growth Fund". A copy of the letter can be downloaded here. The U.S. market saw a strong rally in the second quarter, fu…
Watch Fireside Chat Below, or Click HERE: IPO Edge hosted a fireside chat with Jupiter Neurosciences, Inc. (Nasdaq: JUNS) Chairman, Chief Executive Officer and Co-founder Christer Rosén and Alison Silva, President and Chief Operations Offi…
Billionaire investors such as Peter Thiel and Christian Angermayer are believers in the benefits of using psychedelics derived from magic PREMIUM Upgrade to read this Financial Times article and get so much more. A Silver or Gold subscript…
Wall Street's major averages ended lower on Friday as global technology stocks declined, led by semiconductors and the debut of Moonshot AI's Kimi-K3, which dragged down investor sentiment. The benchmark S&P 500 fell 1%, while the tech-hea…
Key Points The iShares U.S. Pharmaceuticals ETF is larger by assets under management and offers a higher trailing dividend yield. The State Street SPDR S&P Pharmaceuticals ETF has delivered higher one-year returns but experienced a much st…
The iShares U.S. Pharmaceuticals ETF (NYSEMKT:IHE) offers heavy exposure to pharmaceutical giants and a higher yield, while the State Street SPDR S&P Pharmaceuticals ETF (NYSEMKT:XPH) provides broader, more equal-weighted exposure. Both fu…
We recently compiled a list of the 7 Best Psychedelic Stocks to Buy According to Analysts. Definium Therapeutics, Inc. (NASDAQ:DFTX) is one of the best psychedelic stocks on our list. TheFly reported on June 30 that Canaccord reduced its p…
An obscure psychedelic is drawing intense interest from the pharmaceutical industry. WSJ explores why companies are betting hundreds of millions of dollars on the therapeutic potential of a toad poison. View Comments
[Psychedelic Brain Therapy] wildpixel/iStock via Getty Images * A memorandum of understanding brokered Monday between HHS and the Veterans Administration could bode well for companies developing psychedelic-based drug treatments. * The MOU…
Thank you very much for attending! Question Answer Lots of reverb! Close zoom down and re-open the webinar Interesting issue of whether bio/medical, software, financials, small caps are just a rotation play versus an enduring trend, and wh…
The Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) and State Street SPDR S&P Pharmaceuticals ETF (NYSEMKT:XPH) both target healthcare innovation but differ in their diversification levels and cost structures. These two funds provide distin…
We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts. Definium Therapeutics, Inc. (NASDAQ:DFTX) is one of the best biotech stocks on this list. TheFly reported on June 23 that Robert W. Baird analyst Chris…
(RTTNews) - This week, the biotech sector delivered a mix of FDA and EU approvals, strategic reorganizations, layoff, acquisitions, and late-stage clinical readouts across oncology, metabolic disease, neurology and immunology. Regulatory m…
(RTTNews) - Definium Therapeutics, Inc. (DFTX), a late-stage clinical biopharmaceutical company developing therapeutics for psychiatric and neurological disorders, priced a public offering of 20.59 million common shares at $34 per share. T…
Definium Therapeutics (DFTX [https://seekingalpha.com/symbol/DFTX]) has announced the pricing [https://seekingalpha.com/pr/20561672-definium-therapeutics-inc-announces-pricing-of-700-million-upsized-public-offering] of an underwritten publ…
Definium Therapeutics DFTX shares surged 49.8% after the company announced positive top-line results from a late-stage study evaluating its lead pipeline candidate, DT120 orally disintegrating tablet (ODT), in adults with major depressive…
Definium Therapeutics Inc. (NASDAQ:DFTX) is one of the 10 Stocks Paying Off Big Time. Definium Therapeutics saw its share prices jump to a nearly five-year high on Monday, as investors positioned their portfolios after reporting strong res…
The S&P 500 Index ($SPX) (SPY) on Monday closed down -0.37%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.29%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.19%. September E-mini S&P futures (ESU26) fell -0.34%, and…
The S&P 500 Index ($SPX) (SPY) on Monday closed down -0.37%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.29%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.19%. September E-mini S&P futures (ESU26) fell -0.34%, and…
The S&P 500 Index ($SPX) (SPY) today is down -0.40%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.27%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.30%. September E-mini S&P futures (ESU26) are down -0.38%, and September E-…
(RTTNews) - Now that Definium Therapeutics Inc. (DFTX) has reported positive results from its Phase 3 Emerge trial, greater clarity has emerged around the clinical profile and potential of its lead investigational asset, DT120 Orally Disin…
The S&P 500 Index ($SPX) (SPY) today is up +0.21%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.54%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.50%. September E-mini S&P futures (ESU26) are up +0.20%, and September E-mini N…
The S&P 500 Index ($SPX) (SPY) today is down -0.40%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.27%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.30%. September E-mini S&P futures (ESU26) are down -0.38%, and September E-…